Top Headlines
USP and BPC harmonize first finished product monographs
Drug manufacturers will benefit from harmonisation of finished product monographs says the USP after a first of its kind collaboration with the BPC.
Dendreon to slash costs using production automation; CFO
Dendreon hopes to cut its cost of goods sold by two-thirds through automation of tasks at its cancer vaccine plants.
Round-up of new pharmaceutical manufacturing facilities
in-PharmaTechnologist.com presents the latest new facilities to spring up all over the world, including a plasma-based therapy expansion for Baxter, a North African foray for Julphar, and a supply chain step-up for Vetter.
PTI stresses benefits of non-destructive testing at Interphex
PTI says its new non-destructive testing technology is uniquely positioned to help manufacturers reduce waste and save time and money.
Spotlight
ICH sends Q11 guidelines to EU, US & Japanese regulators
The ICH has sent its Q11 guidelines on APIs to regulatory bodies in the US, European Union and Japan for adoption...
in-Pharmatechnologist.com's review of Interphex 2012
in-Pharmatechnologist.com was at Interphex 2012 in New York, US to launch the revamped version of our website and speak to the pharmaceutical manufacturing and processing tech sector’s movers and shakers.
Effective controls still lacking for continuous processing says Interphex panel
Continuous processing is still hamstrung by a lack of control systems and is not ready for specific FDA guidance according to an industry expert panel which met at Interphex last week...
BASF buys omega-3 maker Equateq citing pharma potential
BASF has bought omega-3 fatty acid maker Equateq, citing its pharmaceutical and dietary supplements businesses as key beneficiaries.
EMA outlines manufacturing quality docs for biologics trials
The EMA has published final guidelines on manufacturing quality documents needed for biologics entering clinical trials.
Global Industry News
SNBL invests in animal welfare at US labfrom Outsourcing-Pharma.com
SNBL USA has invested in ‘social housing’ at its lab in Everett, Washington citing ‘recent reductions’ in US non-human primate lab capacity as the driver.
IGI hires after “notable shift” in pharma services demandfrom Outsourcing-Pharma.com
IGI Laboratories has boosted hiring after its pharmaceutical contract manufacturing unit experienced a “notable shift” in demand.
Contract sales deals expirations drive drop in revenues at PDI from Outsourcing-Pharma.com
Expiration of contract sales deals drove a 28 per cent drop in revenue at PDI and pushed financials below analysts’ expectations.
Quality research key to Pharma viability say execs at Avoca Summitfrom Outsourcing-Pharma.com
Ensuring outsourced clinical research is of a high standard is critical to the viability of the pharma sector and requires cross industry collaboration according to leaders gathered at the Avoca Group’s Quality Summit.